Physician profile
Devdatta Gabale
NPI 1992741946
$1,081.66
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $22.12 · 2021: $14.94 · 2022: $78.28 · 2023: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $509.46 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.61 | 2019-2023 | |
| Abbvie INC. | $61.34 | 2019 | |
| Janssen Biotech, INC. | $59.94 | 2019 | |
| Dendreon Pharmaceuticals LLC | $40.64 | 2019 | |
| Endo Pharmaceuticals INC. | $39.93 | 2019 | |
| Pfizer INC. | $39.02 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $25.93 | 2019 | |
| Metuchen Pharmaceuticals | $25.69 | 2019 | |
| Telix Pharmaceuticals | $22.19 | 2023 | Illuccix |
| Jazz Pharmaceuticals INC. | $22.12 | 2020 | |
| Amgen INC. | $20.91 | 2019 | |
| Convatec INC. | $18.99 | 2022 | |
| Medtronic, INC. | $14.94 | 2021 | |
| Boston Scientific Corporation | $12.83 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devdatta Gabale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.